News

US FDA to Issue New Vouchers to Drug Developers to Shorten Review Time
(Reuters) -The U.S. Food and Drug Administration on Tuesday announced that it will issue a new priority review voucher to ...
MAHA Redo at FDA Includes Fast-Tracking Some Drugs, More Use of AI
The FDA regulates products that account for one-fifth of American consumer spending—everything from lettuce to vapes to pet ...
We Spent a Year Investigating How the FDA Let Risky Drugs Into the U.S. Market
Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...
Sandwich Recall Update as FDA Issues Most Severe Risk Warning
The recall level is reserved for when consuming the product could potentially cause adverse health consequences or death.
The American Journal of Managed Care38m
FDA Approves Garadacimab-gxii in Hereditary Angioedema
Garadacimab-gxii is the first and only treatment that targets factor XIIa (FXIIa) for the prophylactic prevention of reditary ...
US FDA extends review of KalVista's swelling disorder drug due to heavy workload
By Puyaan Singh (Reuters) -KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended ...
Futurism on MSN4d
The FDA Is Already Outsourcing Drug and Food Analysis to Error-Plagued AI Chatbot
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
Kraft Heinz removing all artificial dyes from US products by end of 2027
Kraft Heinz plans to remove all artificial dyes from its U.S. products by 2027 amid the Trump administration's push to remove ...
US FDA puts on hold Rein Therapeutics' lung disease drug trial
Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...